Abstract
Genomeditech holds commercial usage rights for HEK293, Jurkat E6.1, and CHO-K1 cell lines.
Genomeditech has the global rights to modify, develop, and engineer HEK293, Jurkat E6.1, and CHO-K1 cell lines, as well as to sell related products worldwide.
Genomeditech offer professional support to help biopharmaceutical developers accelerate development while ensuring compliance.
Introduction
HEK293, CHO, and Jurkat cell lines are extensively utilized in the global biopharmaceutical industry. Their widespread adoption is attributed to their distinct and advantageous biological properties. These cell lines facilitate various research applications, including viral packaging, protein expression, antibody production, gene editing, and signal transduction studies.
Genomeditech has secured commercial usage rights for HEK293, Jurkat E6.1, and CHO-K1 cell lines, allowing the company to modify, develop, and distribute these cell lines. With clear traceability documentation, Genomeditech helps users mitigate intellectual property risks throughout the development process.
Building on this foundation, Genomeditech further supports biopharmaceutical developers by streamlining access to critical cell line resources. This helps customers overcome complex licensing procedures and high authorization costs. It also ensures smooth regulatory compliance from preclinical research to IND/BLA stages—enabling clients to carry out downstream release testing, reduce legal risks, and accelerate the commercialization process.
Genomeditech Advantages
1. Clear Traceability
All cell lines have a complete traceability chain, with comprehensive construction records and experimental reports available. This facilitates global commercialization filings and project transfers for users.
2. Legal Compliance
Genomeditech’s HEK293, Jurkat E6.1, and CHO-K1 cell lines have obtained commercial licensing and usage rights for the original cell lines, effectively avoiding intellectual property and compliance risks.
3. Activity Validation
With a mature cell line construction platform, all cell lines undergo thorough screening and validation. The evaluation system is multidimensional and functional. It includes tests such as receptor-ligand binding affinity and signalling pathway activation efficiency. These measures ensure the biological functionality of the cell lines and the reliability of experimental results.
4. Stable Passaging
All cell lines undergo rigorous screening and validation. Even after generations from a dozen to several dozen, they still maintain high genetic and biological functional stability, ensuring experimental reproducibility and consistency.
5. High Efficiency
Genomeditech's compliant licensing solutions have been optimized and upgraded. By offering low-threshold authorization and clear legal pathways, users can ensure regulatory compliance with greater convenience. Genomeditech provides dedicated support and communication channels throughout the process, helping users navigate licensing procedures smoothly.
Providing HEK293, Jurkat E6.1, and CHO-K1 Related Products
Supported by a skilled development team and a comprehensive quality management system, Genomeditech delivers professional, efficient, and personalized solutions to advance scientific research and ensure project success.
In drug target research, Genomeditech has developed over 1,000 strains of in-stock cell line strains covering more than 400 popular drug targets, including TAA, immune checkpoints, Fc receptors, cytokines, and kinases. These cell lines support research across a wide range of diseases, such as cancer, autoimmune disorders, metabolic diseases, cardiovascular conditions, and infectious viruses. By the end of 2025, the number of in-stock cell lines is expected to expand to 1,500 strains.
Advancing Technology and Expanding Global Collaboration
Genomeditech is committed to continuously advancing its expertise in cell models, protein expression, and antibody development. The company will actively broaden the scope of collaboration and play a proactive role in shaping international standards and industry best practices.
Through high-quality products and reliable services, Genomeditech strives to support the sustainable development of the global biopharmaceutical industry and make meaningful contributions to human health and well-being.
